MicroRNA-29a enhances cisplatin sensitivity in non-small cell lung cancer through the regulation of REV3L

Cisplatin-based chemotherapy may greatly enhance patient prognosis; however, chemotherapy resistance remains an obstacle to curing patients with non-small cell lung cancer (NSCLC). The aim of the present study was to explore the microRNAs (miRs) that could regulate cisplatin sensitivity and provide...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xialin, Zhu, Hong, Ye, Wanli, Cui, Yayun, Chen, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323222/
https://www.ncbi.nlm.nih.gov/pubmed/30535450
http://dx.doi.org/10.3892/mmr.2018.9723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323222/
https://www.ncbi.nlm.nih.gov/pubmed/30535450
http://dx.doi.org/10.3892/mmr.2018.9723

Ejemplares similares